MELISSA DELAMORA: Open Payments
NPI 1003257775 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,248 in 40 payments from 11 companies in 2025. Trend: 2023 $8,306 · 2024 $8,174 · 2025 $2,248
Speaker / faculty: $1,250Food & beverage: $998
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $1,525 |
| SPR Therapeutics, Inc | 2 | $235 |
| PFIZER INC. | 5 | $118 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $84 |
| Amgen Inc. | 3 | $73 |
| Saluda Medical Americas, Inc. | 3 | $56 |
| Abbott Laboratories | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $28 |
Products named: QULIPTA, SPRINT PNS System, VRAYLAR, NURTEC ODT, JOURNAVX, UBRELVY, Evoke, ETERNA.
Industry payments across NV — which companies pay providers there.
